|
Hycult Biotech
human c3a elisa kit Human C3a Elisa Kit, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+c3a/C3a%2C+Human%2C+ELISA+kit/us12595270-839-0-4 Average 94 stars, based on 1 article reviews
human c3a elisa kit - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
ATCC
human hepatocellular carcinoma hepg2 c3a cells Human Hepatocellular Carcinoma Hepg2 C3a Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+c3a/C3A/pmc13753295-25-13-27 Average 96 stars, based on 1 article reviews
human hepatocellular carcinoma hepg2 c3a cells - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
MedChemExpress
human c3a ![]() Human C3a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+c3a/C3a/pmc13748817-133-2-4 Average 94 stars, based on 1 article reviews
human c3a - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Hycult Biotech
mouse monoclonal anti c3 c3a ![]() Mouse Monoclonal Anti C3 C3a, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+c3a/C3%2FC3a%2C+Human%2C+mAb+474/pm42986452-73-18-22 Average 93 stars, based on 1 article reviews
mouse monoclonal anti c3 c3a - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
R&D Systems
spheroids ![]() Spheroids, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+c3a/Recombinant+Human+Complement+Component+C3a+Protein%2C+CF/pm42962879-356-38-33 Average 93 stars, based on 1 article reviews
spheroids - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
ATCC
c3a human liver cells ![]() C3a Human Liver Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+c3a/C3A/pm42716800-46-0-8 Average 96 stars, based on 1 article reviews
c3a human liver cells - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Hycult Biotech
mab clone2898 ![]() Mab Clone2898, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+c3a/C3%2FC3a%2C+Human%2C+mAb+2898/bio_rxiv__64898__2026__06__18__733111-271-15-18 Average 94 stars, based on 1 article reviews
mab clone2898 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
ATCC
human hepatocellular carcinoma hepg2 c3a ![]() Human Hepatocellular Carcinoma Hepg2 C3a, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+c3a/Hep+G2/pmc13112599-173-15-25 Average 99 stars, based on 1 article reviews
human hepatocellular carcinoma hepg2 c3a - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
Roche
human complement c3a elisa kit invitrogen bms2089 human complement c5a elisa kit invitrogen bms2088 kapa hifi hotstart readymix kapa biosystems ![]() Human Complement C3a Elisa Kit Invitrogen Bms2089 Human Complement C5a Elisa Kit Invitrogen Bms2088 Kapa Hifi Hotstart Readymix Kapa Biosystems, supplied by Roche, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+c3a/KAPA+HiFi+Kit/pm41997144-265-207-225 Average 99 stars, based on 1 article reviews
human complement c3a elisa kit invitrogen bms2089 human complement c5a elisa kit invitrogen bms2088 kapa hifi hotstart readymix kapa biosystems - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
human c3a ![]() Human C3a, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+c3a/C3A/pm41771535-188-0-4 Average 96 stars, based on 1 article reviews
human c3a - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
Journal: CNS Neuroscience & Therapeutics
Article Title: C3a‐ C3aR Signaling Modulates Neutrophil Extracellular Traps Formation and Contributes to Blood–Brain Barrier Injury After Stroke
doi: 10.1002/cns.71239
Figure Lengend Snippet: C3a‐C3aR signaling was identified as a potential key regulator associated with NETs formation. (A, C) Heatmap of genes enriched regarding the NETs formation and complement cascade ( n = 3). C3 and C3aR are involved in complement cascade and NETs formation. (B) KDA provides that C3aR is a key driver in influencing the expression of other genes. (D) Quantification of mRNA of C1qa, C3, C3aR, C4, and C5 using RT‐qPCR 3 days after stroke ( n = 6 in the sham group, and n = 7 in the stroke group). (E) WB bands in 2 groups 3 days after stroke. (F–H) Protein expression of C1q, C3, and C3aR normalized to β‐actin ( n = 4). (I) C3aR expressed on the neutrophils. Scale bar = 50 μm or 20 μm (zoom). (J) The colocalization experiment showing the fluorescent signals of C3aR and HIS48. The density plot illustrates the fluorescence intensity in colocalized regions, indicating a spatial overlap. (K) Co‐IP results of C3aR and C3, showing an association between C3‐derived material and C3aR in tissue lysates. Stroke group versus sham group, data as mean ± SEM. * p < 0.05, ** p < 0.01, and *** p < 0.001.
Article Snippet: The purified
Techniques: Expressing, Quantitative RT-PCR, Fluorescence, Co-Immunoprecipitation Assay, Derivative Assay, Tissue
Journal: CNS Neuroscience & Therapeutics
Article Title: C3a‐ C3aR Signaling Modulates Neutrophil Extracellular Traps Formation and Contributes to Blood–Brain Barrier Injury After Stroke
doi: 10.1002/cns.71239
Figure Lengend Snippet: Inhibition of C3a‐C3aR signaling was associated with reduced NETs formation, BBB damage, and neurological impairment after stroke. (A) The flow diagram of an experiment in this part. The animals received intraperitoneal injections of the C3aR antagonist (C3aRA) SB290157 or vehicle for five consecutive days, starting 2 days before tMCAO. On day 3 after tMCAO, behavioral tests were performed, and brain tissue was harvested. (B, C) mNSS score ( n = 9) and MST ratio ( n = 7) in the vehicle and C3aRA groups. (D) Survival curve of the vehicle and C3aRA groups from day 0 to day 7 after stroke ( n = 9). (E) Trajectory plots and open field movement heatmap in the vehicle and C3aRA groups. (F, G) Average speed and total distance in the vehicle and C3aRA groups ( n = 7). (H) Survival rate in the vehicle and C3aRA groups ( n = 9). (I) Quantification of cfDNA in the blood of the vehicle and C3aRA groups ( n = 5). (J) Quantification of NETs in the vehicle and C3aRA groups ( n = 9 FOVs of 3 rats, 3 FOVs per rat). (K) Images of NETs in the vehicle and C3aRA groups. Scale bar = 50 μm or 20 μm (zoom). (L) WB bands of the vehicle and C3aRA groups. (M–P) Protein expression of C3aR, CitH3, Occludin, and ZO‐1 normalized to GAPDH or H3 ( n = 4). (Q) Image of BBB leakage using Evans blue dye in the vehicle and C3aRA groups. (R) Image of BBB leakage using biotin staining in the vehicle and C3aRA groups. Scale bar = 20 μm. (S) Images of CD31 co‐labeled with ZO‐1 or Occludin in the vehicle and C3aRA groups. Scale bar = 50 μm. (T, U) Quantification of Evans blue dye ( n = 4) and biotin staining ( n = 9 FOVs of 3 rats, 3 FOVs per rat) in the vehicle and C3aRA groups. (V, W) Quantification of CD31 co‐labeled with ZO‐1 or Occludin in the vehicle and C3aRA groups ( n = 9 FOVs of 3 rats, 3 FOVs per rat). (X) Ultrastructure alteration of the tight junction near the endothelial cell. Scale bar = 1 μm and 0.5 μm. C3aRA group versus vehicle group, data as mean ± SEM. * p < 0.05, ** p < 0.01, and *** p < 0.001.
Article Snippet: The purified
Techniques: Inhibition, Tissue, Expressing, Staining, Labeling
Journal: CNS Neuroscience & Therapeutics
Article Title: C3a‐ C3aR Signaling Modulates Neutrophil Extracellular Traps Formation and Contributes to Blood–Brain Barrier Injury After Stroke
doi: 10.1002/cns.71239
Figure Lengend Snippet: Activation of C3a‐C3aR signaling was associated with increased NETs formation, BBB damage, and neurological impairment after stroke. (A) The flow diagram of an experiment in this part. The animals received intranasal administration of C3a or vehicle for seven consecutive days, starting 4 days before tMCAO. On day 3 after tMCAO, behavioral tests were performed, and brain tissue was harvested. (B, C) mNSS score ( n = 9) and MST ratio ( n = 7) in the control and C3a groups. (D) Total distance in the control and C3a groups ( n = 7). (E) Trajectory plots and open field movement heatmap in the control and C3a groups. (F) Average speed in the control and C3a groups ( n = 7). (G) Quantification of NETs in the control and C3a groups ( n = 9 FOVs of 3 rats, 3 FOVs per rat). (H) Levels of C3a in blood and cortex in the control and C3a groups ( n = 3). (I, J) Quantification of C3aR and CitH3 expression in the control and C3a groups ( n = 4). (K) Images of NETs in the control and C3a groups. Scale bar = 50 μm or 20 μm (zoom). (L) WB bands in the control and C3a groups. (M–O) Quantification of PAD4, ZO‐1, and Occludin expression in the control and C3a groups ( n = 4). (P) Image of BBB leakage using Evans blue dye in the control and C3a groups. (Q) Image of BBB leakage using biotin staining in the control and C3a groups. Scale bar = 20 μm. (R, S) Quantification of biotin staining ( n = 9 FOVs of 3 rats, 3 FOVs per rat) and Evans blue dye ( n = 4) in the control and C3a groups. (T) Images of CD31 co‐labeled with ZO‐1 or Occludin in the control and C3a groups. Scale bar =20 μm. (U, V) Quantification of CD31 co‐labeled with ZO‐1 or Occludin in the control and C3a groups ( n = 9 FOVs of 3 rats, 3 FOVs per rat). (W) Ultrastructure alteration of the tight junction near the endothelial cell. Scale bar = 1 μm or 0.5 μm (zoom). C3a group versus control group, data as mean ± SEM. * p < 0.05, ** p < 0.01, and *** p < 0.001.
Article Snippet: The purified
Techniques: Activation Assay, Tissue, Control, Expressing, Staining, Labeling
Journal: MicrobiologyOpen
Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria
doi: 10.1002/mbo3.70270
Figure Lengend Snippet: Effect of 10 Gy X‐ray on viability of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells. Blue: untreated controls; Pink: irradiated cells. Cell counts were conducted at 24, 48, and 72 h post‐treatment. Statistical analysis was performed using two‐way ANOVA with Tukey's post hoc test: p < 0.05 (*), p < 0.005 (**), p < 0.0005 (***), p < 0.0001 (****), n = 3. Note: Y ‐axes are scaled independently for each cell line to account for differences in baseline growth, allowing clearer visualization of treatment effects. Tumor cell counts and representative images can be found in Appendix Table and Figure .
Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC),
Techniques: Irradiation
Journal: MicrobiologyOpen
Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria
doi: 10.1002/mbo3.70270
Figure Lengend Snippet: Images of untreated NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells and cells exposed to X‐ray. Scalebar: 300 µm.
Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC),
Techniques:
Journal: MicrobiologyOpen
Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria
doi: 10.1002/mbo3.70270
Figure Lengend Snippet: Viability of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells after treatment with IMP‐1700 (5 µM), ciprofloxacin (CPX) (15 µM), their combination, or DMSO, with and without 10 Gy X‐ray. Cell counts were measured at 24, 48, and 72 h post‐treatment. Statistical significance assessed via two‐way ANOVA and Tukey's post hoc test: p < 0.05 (*), p < 0.005 (**), p < 0.0005 (***), p < 0.0001 (****), n = 3. Significant differences are only shown compared to untreated or 10 Gy. Tumor cell count values and images are available in Appendix Table and Figure , , , .
Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC),
Techniques: Cell Characterization
Journal: MicrobiologyOpen
Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria
doi: 10.1002/mbo3.70270
Figure Lengend Snippet: Images of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells treated with IMP‐1700, with and without X‐ray. Scalebar: 300 µm.
Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC),
Techniques:
Journal: MicrobiologyOpen
Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria
doi: 10.1002/mbo3.70270
Figure Lengend Snippet: Images of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells treated with ciprofloxacin (CPX), with and without X‐ray. Scalebar: 300 µm.
Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC),
Techniques:
Journal: MicrobiologyOpen
Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria
doi: 10.1002/mbo3.70270
Figure Lengend Snippet: Images of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells treated with IMP‐1700 and ciprofloxacin (CPX), with and without X‐ray. Scalebar: 300 µm.
Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC),
Techniques:
Journal: MicrobiologyOpen
Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria
doi: 10.1002/mbo3.70270
Figure Lengend Snippet: Images of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells treated with DMSO, with and without X‐ray. Scalebar: 300 µm.
Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC),
Techniques: